Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January 14, 2019, Michael G. Combs, the President of CorVel Corporation (the “Company”), was appointed to the additional office of Chief Executive Officer of the Company effective as of January 18, 2019. In connection with Mr. Combs’ appointment and in accordance with the Company’s Bylaws, V. Gordon Clemons resigned his title as Chief Executive Officer of the Company effective as of January 18, 2019, but will continue to serve as Chairman of the Company and will remain an employee of the Company focusing his attentions on strategy and product development.
Mr. Combs, 55 years old, was previously promoted to President in April 2017 and served as Chief Information Officer from April 2015 to April 2017. Mr. Combs has been with the Company for 27 years, initially joining the Company as a software engineer in 1988. He held positions as Vice President of MedCheck Development in 2005 and Deputy Chief Information Officer in 2014. Mr. Combs’ compensation is described in the Company’s proxy statement filed on June 22, 2018. If the Company’s Compensation Committee approves a material change to Mr. Combs’ compensation or grants a material stock option to Mr. Combs in connection with this appointment, the Company will file an amendment to this Form 8K. There are no family relationships between Mr. Combs and any other director or executive officer of the Company.
Item 7.01. | Regulation FD Disclosure. |
On January 18, 2019, the Company issued a press release announcing the appointment of Mr. Combs as Chief Executive Officer of the Company. A copy of the press release is attached hereto as Exhibit 99.1.
The information included in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. | Financial Statements and Exhibits. |